Close Menu

This article from the Wall Street Journal ($) reports on a consortium that will shut down a series of cancer clinical trials due to insufficient federal funding. The Coalition of Cancer Cooperative Groups will reduce its trials by some 3,000 patients this year, which will mostly affect studies of less common cancers, according to the article.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.